Chemoinformaics analysis of Pentamethylbenzene
| Molecular Weight | 148.249 | nRot | 0 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 7 |
| Exact Molecular Weight | 148.125 | nRing | 1 |
| Solubility: LogS | -1.906 | nHRing | 0 |
| Solubility: LogP | 2.241 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 29.0387 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.528 |
| Synth | 3.523 |
| Natural Product Likeliness | 2.238 |
| NR-PPAR-gamma | 0.031 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.355 |
| MDCK | 0.000022 |
| BBB | 0.989 |
| PPB | 0.912145 |
| VDSS | 1.296 |
| FU | 0.090864 |
| CYP1A2-inh | 0.543 |
| CYP1A2-sub | 0.744 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.857 |
| CYP2c9-inh | 0.119 |
| CYP2c9-sub | 0.518 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.531 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.382 |
| CL | 6.925 |
| T12 | 0.836 |
| hERG | 0.003 |
| Ames | 0.102 |
| ROA | 0.111 |
| SkinSen | 0.05 |
| Carcinogencity | 0.848 |
| EI | 0.505 |
| Respiratory | 0.783 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.773887 |